[go: up one dir, main page]

DE3280308D1 - Verwendung von nadolol zur herstellung peroraler formen fuer die behandlung von glaukom. - Google Patents

Verwendung von nadolol zur herstellung peroraler formen fuer die behandlung von glaukom.

Info

Publication number
DE3280308D1
DE3280308D1 DE8282103450T DE3280308T DE3280308D1 DE 3280308 D1 DE3280308 D1 DE 3280308D1 DE 8282103450 T DE8282103450 T DE 8282103450T DE 3280308 T DE3280308 T DE 3280308T DE 3280308 D1 DE3280308 D1 DE 3280308D1
Authority
DE
Germany
Prior art keywords
nadolol
glaucoma
treatment
production
peroral forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8282103450T
Other languages
English (en)
Inventor
Abraham Sudilovsky
John Gordon Muir
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/257,453 external-priority patent/US4402976A/en
Priority claimed from US06/277,378 external-priority patent/US4346106A/en
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of DE3280308D1 publication Critical patent/DE3280308D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE8282103450T 1981-04-24 1982-04-23 Verwendung von nadolol zur herstellung peroraler formen fuer die behandlung von glaukom. Expired - Fee Related DE3280308D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/257,453 US4402976A (en) 1981-04-24 1981-04-24 Method for treating glaucoma with systemic nadolol compositions
US26365681A 1981-05-14 1981-05-14
US06/277,378 US4346106A (en) 1981-05-14 1981-06-25 Method for inhibiting onset of migraine headaches with nadolol compositions

Publications (1)

Publication Number Publication Date
DE3280308D1 true DE3280308D1 (de) 1991-04-04

Family

ID=27401043

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282103450T Expired - Fee Related DE3280308D1 (de) 1981-04-24 1982-04-23 Verwendung von nadolol zur herstellung peroraler formen fuer die behandlung von glaukom.

Country Status (2)

Country Link
EP (2) EP0350080A3 (de)
DE (1) DE3280308D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2870459B2 (ja) * 1995-10-09 1999-03-17 日本電気株式会社 インクジェット記録装置及びその製造方法
EP1799264A2 (de) * 2004-10-08 2007-06-27 Neuromolecular Pharmaceuticals Inc Verfahren und zusammensetzungen zur behandlung von migräne
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
CA2604052C (en) 2005-04-06 2014-07-08 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of cns-related conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130393C3 (de) 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-Dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanole und ihre Salze mit Säuren sowie ihre Verwendung bei der Bekämpfung von Herzerkrankungen
US3982021A (en) * 1971-12-01 1976-09-21 E. R. Squibb & Sons, Inc. Compositions for the treatment of coronary diseases containing tetrahydronaphthyloxy-aminopropanols
GB1559987A (en) 1975-11-06 1980-01-30 Squibb & Sons Inc 1,2,3,4-tetrahydronaphthalene derivatives
US4281654A (en) * 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy

Also Published As

Publication number Publication date
EP0350080A2 (de) 1990-01-10
EP0064646A1 (de) 1982-11-17
EP0064646B1 (de) 1991-02-27
EP0350080A3 (de) 1990-01-24

Similar Documents

Publication Publication Date Title
DE3855525D1 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
DE69018178D1 (de) Verfahren zur Herstellung von Disilan.
ATE13414T1 (de) Verfahren zur herstellung von faellungskieselsaeuren.
DE3789881D1 (de) Verfahren zur Herstellung von Photomasken und Photomaske.
DE69001484D1 (de) Verwendung von menschlichen bcdf fuer die herstellung einer zusammensetzung fuer die behandlung von thrombocytopenia.
DE59106083D1 (de) Verfahren zur Herstellung von Polyisobuten.
DE3751018D1 (de) Verfahren zur Herstellung von direkt-positiven Bildern.
DE3788399D1 (de) Verfahren zur Herstellung von eingekapseltem Toner.
DE68916393D1 (de) Verfahren zur Herstellung von ebenen Wafern.
DE3750318D1 (de) Verfahren zur Herstellung von Halosilanen.
DE69101530D1 (de) Flockungsmittel für Wasseraufbereitung und Verfahren für seine Herstellung.
DE59008850D1 (de) Verfahren zur Herstellung von Brustprothesen.
DE69111163D1 (de) Verfahren zur Herstellung von stabilem Latex.
DE3776819D1 (de) Vorrichtung fuer die herstellung von filterzigaretten.
ATE2665T1 (de) Verfahren zur herstellung von niederen alkoholen.
ATE3411T1 (de) Verfahren zur herstellung von 2,6dialkylcyclohexylaminen.
DE3280308D1 (de) Verwendung von nadolol zur herstellung peroraler formen fuer die behandlung von glaukom.
DE69113146D1 (de) Verfahren zur Herstellung von Silikongummiformteilen.
DE58901037D1 (de) Vorrichtung zur herstellung von klareisstuecken.
DE69109574D1 (de) Verfahren zur Herstellung von Trifluoroethylen.
ATE21508T1 (de) Verfahren zur herstellung von alphahaloalkylamiden.
DE59007701D1 (de) Verfahren zur Herstellung von Vinyltrichlorsilan.
DE3784768D1 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.
ATE60992T1 (de) Verwendung von nadolol zur herstellung peroraler formen fuer die behandlung von glaukom.
DE69014042D1 (de) Verfahren zur Herstellung von menschlichem Osteocalcin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee